Center-Authored Papers

Filters: Author is Vessella, Robert L  [Clear All Filters]
2002
Wilbur SD, Hamlin DK, Meyer DL, Mallett RW, Quinn J, Vessella RL, Press OW.  2002.  Streptavidin in antibody pretargeting. 3. Comparison of biotin binding and tissue localization of 1,2-cyclohexanedione and succinic anhydride modified recombinant streptavidin.. Bioconjugate chemistry. 13(3):611-20. Abstract
2008
Morrissey C, True LD, Roudier MP, Coleman IM, Hawley S, Nelson PS, Coleman R, Wang Y-C, Corey E, Lange PH et al..  2008.  Differential expression of angiogenesis associated genes in prostate cancer bone, liver and lymph node metastases.. Clinical & experimental metastasis. 25(4):377-88. Abstract
Holcomb IN, Grove DI, Kinnunen M, Friedman CL, Gallaher IS, Morgan TM, Sather CL, Delrow JJ, Nelson PS, Lange PH et al..  2008.  Genomic alterations indicate tumor origin and varied metastatic potential of disseminated cells from prostate cancer patients.. Cancer research. 68(14):5599-608. Abstract
Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A et al..  2008.  Circulating microRNAs as stable blood-based markers for cancer detection.. Proceedings of the National Academy of Sciences of the United States of America. 105(30):10513-8. Abstract
Knudsen BS, Allen AN, McLerran DF, Vessella RL, Karademos J, Davies JE, Maqsodi B, McMaster GK, Kristal AR.  2008.  Evaluation of the branched-chain DNA assay for measurement of RNA in formalin-fixed tissues.. The Journal of molecular diagnostics : JMD. 10(2):169-76. Abstract
2009
Sprenger CCT, Haugk K, Sun S, Coleman I, Nelson PS, Vessella RL, Ludwig DL, Wu JD, Plymate SR.  2009.  Transforming Growth Factor-{beta}-Stimulated Clone-22 Is an Androgen-Regulated Gene That Enhances Apoptosis in Prostate Cancer following Insulin-Like Growth Factor-I Receptor Inhibition.. Clinical cancer research : an official journal of the American Association for Cancer Research. 15(24):7634-7641. Abstract
Koreckij TD, Trauger RJ, Montgomery RB, Pitts TEM, Coleman I, Nguyen H, Reading CL, Nelson PS, Vessella RL, Corey E.  2009.  HE3235 inhibits growth of castration-resistant prostate cancer.. Neoplasia (New York, N.Y.). 11(11):1216-25. Abstract
Holcomb IN, Young JM, Coleman IM, Salari K, Grove DI, Hsu L, True LD, Roudier MP, Morrissey CM, Higano CS et al..  2009.  Comparative analyses of chromosome alterations in soft-tissue metastases within and across patients with castration-resistant prostate cancer.. Cancer research. 69(19):7793-802. Abstract
2010
Morrissey C, Gallis B, Solazzi JW, Kim BJ, Gulati R, Vakar-Lopez F, Goodlett DR, Vessella RL, Sasaki T.  2010.  Effect of artemisinin derivatives on apoptosis and cell cycle in prostate cancer cells.. Anti-cancer drugs. 21(4):423-32. Abstract
Sun S, Sprenger CCT, Vessella RL, Haugk K, Soriano K, Mostaghel EA, Page ST, Coleman IM, Nguyen HM, Sun H et al..  2010.  Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant.. The Journal of clinical investigation. 120(8):2715-30. Abstract
Morrissey C, Lai JS, Brown LG, Wang Y-C, Roudier MP, Coleman IM, Gulati R, Vakar-Lopez F, True LD, Corey E et al..  2010.  The expression of osteoclastogenesis-associated factors and osteoblast response to osteolytic prostate cancer cells.. The Prostate. 70(4):412-24. Abstract
2011
Zhang X, Morrissey C, Sun S, Ketchandji M, Nelson PS, True LD, Vakar-Lopez F, Vessella RL, Plymate SR.  2011.  Androgen receptor variants occur frequently in castration resistant prostate cancer metastases.. PloS one. 6(11):e27970. Abstract
Putzke AP, Ventura AP, Bailey AM, Akture C, Opoku-Ansah J, Celiktaş M, Hwang MS, Darling DS, Coleman IM, Nelson PS et al..  2011.  Metastatic progression of prostate cancer and e-cadherin regulation by zeb1 and SRC family kinases.. The American journal of pathology. 179(1):400-10. Abstract
Kumar A, White TA, MacKenzie AP, Clegg N, Lee C, Dumpit RF, Coleman I, Ng SB, Salipante SJ, Rieder MJ et al..  2011.  Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers.. Proceedings of the National Academy of Sciences of the United States of America. 108(41):17087-92. Abstract
Mostaghel EA, Marck BT, Plymate SR, Vessella RL, Balk S, Matsumoto AM, Nelson PS, Montgomery BR.  2011.  Resistance to CYP17A1 Inhibition with Abiraterone in Castration-Resistant Prostate Cancer: Induction of Steroidogenesis and Androgen Receptor Splice Variants.. Clinical cancer research : an official journal of the American Association for Cancer Research. 17(18):5913-25. Abstract
2012
Goel HL, Chang C, Pursell B, Leav I, Lyle S, Xi HS, Hsieh C-C, Adisetiyo H, Roy-Burman P, Coleman I et al..  2012.  VEGF/Neuropilin-2 regulation of Bmi-1 and consequent repression of IGF-1R define a novel mechanism of aggressive prostate cancer.. Cancer discovery. Abstract
2013
Nguyen HM, Ruppender N, Zhang X, Brown LG, Gross TS, Morrissey C, Gulati R, Vessella RL, Schimmoller F, Aftab DT et al..  2013.  Cabozantinib inhibits growth of androgen-sensitive and castration-resistant prostate cancer and affects bone remodeling.. PloS one. 8(10):e78881. Abstract
Cheng HH, Mitchell PS, Kroh EM, Dowell AE, Chéry L, Siddiqui J, Nelson PS, Vessella RL, Knudsen BS, Chinnaiyan AM et al..  2013.  Circulating microRNA profiling identifies a subset of metastatic prostate cancer patients with evidence of cancer-associated hypoxia.. PloS one. 8(7):e69239. Abstract
Welty CJ, Coleman I, Coleman R, Lakely B, Xia J, Chen S, Gulati R, Larson SR, Lange PH, Montgomery B et al..  2013.  Single cell transcriptomic analysis of prostate cancer cells.. BMC molecular biology. 14:6. Abstract
Akfirat C, Zhang X, Ventura A, Berel D, Colangelo ME, Miranti CK, Krajewska M, Reed JC, Higano CS, True LD et al..  2013.  Tumor Cell Survival Mechanisms in Lethal Metastatic Prostate Cancer Differ Between Bone and Soft Tissue Metastases.. The Journal of pathology. Abstract
Larson SR, Zhang X, Dumpit R, Coleman I, Lakely B, Roudier M, Higano CS, True LD, Lange PH, Montgomery B et al..  2013.  Characterization of osteoblastic and osteolytic proteins in prostate cancer bone metastases.. The Prostate. 73(9):932-40. Abstract
Ho ME, Quek S-I, True LD, Morrissey C, Corey E, Vessella RL, Dumpit R, Nelson PS, Maresh EL, Mah V et al..  2013.  Prostate cancer cell phenotypes based on AGR2 and CD10 expression.. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 26(6):849-859. Abstract
Larson SR, Chin J, Zhang X, Brown LG, Coleman IM, Lakely B, Tenniswood M, Corey E, Nelson PS, Vessella RL et al..  2013.  Prostate cancer derived prostatic acid phosphatase promotes an osteoblastic response in the bone microenvironment.. Clinical & experimental metastasis. Abstract
Hindson CM, Chevillet JR, Briggs HA, Gallichotte EN, Ruf IK, Hindson BJ, Vessella RL, Tewari M.  2013.  Absolute quantification by droplet digital PCR versus analog real-time PCR.. Nature methods. 10(10):1003-5. Abstract
2014
Mostaghel EA, Morgan A, Zhang X, Marck BT, Xia J, Hunter-Merrill R, Gulati R, Plymate S, Vessella RL, Corey E et al..  2014.  Prostate cancer characteristics associated with response to pre-receptor targeting of the androgen axis.. PloS one. 9(10):e111545. Abstract